Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from diabetes

Dragons’ Den’s Sara Davies says she was on borderline of early-onset diabetes

The 40-year-old businesswoman says she has since changed her diet due to her concerns.

Evening Standard

Top aging expert says these 4 FDA-approved drugs hold promise for extending life

Dr. Nir Barzilai says a successful gerotherapy will do these four things.

Fortune

Inside Kelly Clarkson’s Weight Loss Journey: It’s More Than Diet And Excercise

Explore Kelly Clarkson's weight loss journey, where she overcame weight struggles through lifestyle changes, diet and exercise, and even medication. The post Inside Kelly Clarkson’s Weight Loss Journey: It’s More Than Diet And Excercise first appeared on Bored Panda.

Bored Panda

From analysis to the latest developments in health,
read the most diverse news in one place.

Apple is testing a new blood-sugar product, but it's not the Apple Watch update we've been waiting for

Apple is testing a new app to help customers with prediabetes.

TechRadar

New blood test could identify children at risk of diabetes, liver ills

Scientists have developed a novel blood test that uses lipids to identify children who are more susceptible to obesity-related problems like diabetes. Read further on Dynamite News:

Dynamite News

Meal Timing Matters For Diabetes: Study Recommends Time-Restricted Eating For Blood Sugar Control

The researchers recommend adopting time-restricted eating as an alternative dietary strategy for diabetic patients were individualized dietary plans do not work or cannot be accessed.

Medical Daily

Ozempic Outperformed 7 Diabetes Medications in Reducing the Risk for Alzheimer’s Disease

Semaglutide outperformed 7 diabetes medications in reducing risk of Alzheimer's disease, according to a study of over 1 million patients with type 2 diabetes.

Inverse

Read news from The Economist, FT, and more,
with one subscription

Diabetes Onset Before 40 Raises Risk Of Death To Four Times: Study

Diagnosing diabetes before 40 quadrupled the risk of early death and later onset was linked to a one-and-a-half times higher risk of death compared with the general population without the condition.

Medical Daily

For type 2 diabetes, focusing on when you eat – not what – can help control blood sugar

Type 2 diabetes affects 1.2 million Australians and accounts for 85-90% of all diabetes cases. This chronic condition is characterised by high blood glucose (sugar) levels, which carry serious health risks. Complications include heart disease, kidney failure and vision problems.

The Conversation

Ozempic and Wegovy may be the newest breakthrough in Alzheimer's prevention

A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing Alzheimer’s disease.

Fortune

Popular Weight Loss Drugs Ozempic, Wegovy May Lower Alzheimer's Disease Risk

Type-2 diabetes patients taking the active ingredient in the drugs, semaglutide, "had a significantly lower risk" of developing the disease, the study found

International Business Times

Even Single Jog Reduces Diabetes Risk, Benefits Notable By Next Day: Says Study

The study reveals that even a single bout of exercise could help reduce type 2 diabetes risk factors, with benefits notable by the next day.

Medical Daily

Ozempic and Wegovy are trimming waistlines—and showing how quickly U.S. health care can turn into a gold rush

The GLP-1 phenomenon is making the fragmentation and dysfunction of the U.S. health care system even more apparent.

Fortune

Can a Low-Carb Diet Reverse Type 2 Diabetes? A New Study Suggests It Might

A new study out this week suggests that sticking to the diet could even help improve beta-cell function in people with type 2 diabetes.

Inverse

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

Is Eli Lilly Still a Top Healthcare Stock After Its Blockbuster Drug Approval?

Pharmaceutical giant Eli Lilly and Company (LLY) is on an impressive run after winning Food and Drug Administration approval for a new eczema drug called Ebglyss. As the company expands its reach in the diabetes, obesity, and eczema markets, is it a must-have in your healthcare portfolio? Read on to…

The Independent UK

Scientists warn of food that may be particularly harmful for people with diabetes

Diet sodas, processed cookies and cereals strongly linked to higher blood sugar levels in people with type 2 diabetes

The Independent UK

Wes Streeting’s NHS revolution laid out in 10-year plan with smartwatches to monitor diabetes

Community-led treatment will be part of health secretary’s initiative

The Guardian - US

Weight-loss drugs could be key reason why US obesity rates falling, experts say

Medications like Ozempic ‘transformed’ diabetes care because they improved health outcomes, say experts

Get all your
news in one place.

100’s of premium titles.
One news app.

Cycling News

Declan Irvine uses 'pioneer' eating skills to manage diabetes and battle Life Time Grand Prix riders at Big Sugar Gravel

Team Novo Nordisk rider among a trio of top Australians in elite men's field

The Independent UK

Weight loss drug Ozempic and type 2 diabetes jabs could be used to tackle binge drinking

Doctors and NHS England’s chief warned this week demand for weight-loss jabs could overwhelm the health services

inkl

Beyond Blood Sugar: How Diabetes Medications Are Transforming Weight Loss Efforts

Diabetes medications have started to gain attention for something other than their intended purpose: weight loss. Originally designed to manage blood sugar levels in patients with diabetes, these medications are now proving to be effective tools in the fight against obesity. As research grows, the narrative surrounding these drugs has…

Inverse

This Common Diabetes Drug Was Thought to Revolutionize Cancer — Here’s What Happened Instead

Population and animal studies suggested metformin could treat cancer, but the clinical trials were a bust. Here’s what happened and what potential may remain.

The Guardian - UK

Weight-loss drug firm accused of prioritising profits after halting insulin pen production

Novo Nordisk’s decision will force people in developing countries to use outdated glass vials and syringes, warn campaigners

The Conversation

Glucose monitors for diabetes have finally been funded – but a chronic workforce shortage will limit the benefits

Pharmac’s decision to fund continuous glucose monitors and automated insulin delivery systems for the approximately 18,000 people who currently live with type 1 diabetes in Aotearoa New Zealand is good news.

The Independent UK

UK’s largest ever research programme could be ‘game changer’ for cancer

The Our Future Health programme aims to transform the prevention, detection and treatment of conditions like dementia, cancer, and diabetes.

1 … 19 20 21 22

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Medical Pharmaceuticals

125 stories

Dexcom

77 stories

Science Photo Library

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.